Ekso Bionics Holdings Inc
F:23E2

Watchlist Manager
Ekso Bionics Holdings Inc Logo
Ekso Bionics Holdings Inc
F:23E2
Watchlist
Price: 3.315 EUR Market Closed
Market Cap: €60.2m

Relative Value

The Relative Value of one Ekso Bionics Holdings Inc stock under the Base Case scenario is 5.144 EUR. Compared to the current market price of 3.315 EUR, Ekso Bionics Holdings Inc is Undervalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
5.144 EUR
Undervaluation 36%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Ekso Bionics Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Ekso Bionics Holdings Inc
F:23E2
33.8m EUR 2.5 -3.4 -3.8 -3.3
US
Abbott Laboratories
NYSE:ABT
194.9B USD 4.4 29.9 16.9 23.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
178.4B USD 17.7 62.4 47.6 57.6
US
Stryker Corp
NYSE:SYK
138.7B USD 5.5 42.7 21.7 26.2
IE
Medtronic PLC
NYSE:MDT
130.4B USD 3.8 27.4 15.3 22.2
US
Boston Scientific Corp
NYSE:BSX
110.1B USD 5.7 39.5 23.5 32
DE
Siemens Healthineers AG
XETRA:SHL
46.3B EUR 2 21.8 12 17
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.8B USD 12 48.9 34.9 38.5
US
Becton Dickinson and Co
NYSE:BDX
48.9B USD 2.2 29.2 11.2 19
US
Edwards Lifesciences Corp
NYSE:EW
44.9B USD 7.6 32.8 23.3 25.5
US
Resmed Inc
NYSE:RMD
38.7B USD 7.2 26.1 18.4 20.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Ekso Bionics Holdings Inc
F:23E2
Average EV/EBITDA: 22.5
Negative Multiple: -3.8
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.9
9%
1.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
47.6
24%
2
US
Stryker Corp
NYSE:SYK
21.7
12%
1.8
IE
Medtronic PLC
NYSE:MDT
15.3
8%
1.9
US
Boston Scientific Corp
NYSE:BSX
23.5
22%
1.1
DE
Siemens Healthineers AG
XETRA:SHL
12
11%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.9
11%
3.2
US
Becton Dickinson and Co
NYSE:BDX
11.2
8%
1.4
US
Edwards Lifesciences Corp
NYSE:EW
23.3
13%
1.8
US
Resmed Inc
NYSE:RMD
18.4
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Ekso Bionics Holdings Inc
F:23E2
Average EV/EBIT: 28.2
Negative Multiple: -3.3
N/A N/A
US
Abbott Laboratories
NYSE:ABT
23.1
17%
1.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
57.6
25%
2.3
US
Stryker Corp
NYSE:SYK
26.2
16%
1.6
IE
Medtronic PLC
NYSE:MDT
22.2
17%
1.3
US
Boston Scientific Corp
NYSE:BSX
32
32%
1
DE
Siemens Healthineers AG
XETRA:SHL
17
15%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.5
11%
3.5
US
Becton Dickinson and Co
NYSE:BDX
19
21%
0.9
US
Edwards Lifesciences Corp
NYSE:EW
25.5
14%
1.8
US
Resmed Inc
NYSE:RMD
20.5
12%
1.7